Monitoring and achievement of target serum urate among gout patients receiving long-term urate lowering therapy in the ACR's RISE Registry.

Among gout patients receiving long-term ULT followed longitudinally by rheumatologists, more than half had a documented SU and among those tested, three quarters achieved the recommended SU target. Routine monitoring of SU is a first step toward improving quality of care for patients with gout. This article is protected by copyright. All rights reserved.